These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 14573386

  • 1. Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats.
    Koch S, Hemrick-Luecke SK, Thompson LK, Evans DC, Threlkeld PG, Nelson DL, Perry KW, Bymaster FP.
    Neuropharmacology; 2003 Dec; 45(7):935-44. PubMed ID: 14573386
    [Abstract] [Full Text] [Related]

  • 2. Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors.
    Bymaster FP, Dreshfield-Ahmad LJ, Threlkeld PG, Shaw JL, Thompson L, Nelson DL, Hemrick-Luecke SK, Wong DT.
    Neuropsychopharmacology; 2001 Dec; 25(6):871-80. PubMed ID: 11750180
    [Abstract] [Full Text] [Related]

  • 3. Brain region-specific effects of short-term treatment with duloxetine, venlafaxine, milnacipran and sertraline on monoamine metabolism in rats.
    Muneoka K, Shirayama Y, Takigawa M, Shioda S.
    Neurochem Res; 2009 Mar; 34(3):542-55. PubMed ID: 18751896
    [Abstract] [Full Text] [Related]

  • 4. Simultaneous increases of extracellular monoamines in microdialysates from hypothalamus of conscious rats by duloxetine, a dual serotonin and norepinephrine uptake inhibitor.
    Engleman EA, Perry KW, Mayle DA, Wong DT.
    Neuropsychopharmacology; 1995 Jul; 12(4):287-95. PubMed ID: 7576005
    [Abstract] [Full Text] [Related]

  • 5. S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.
    Millan MJ, Gobert A, Lejeune F, Newman-Tancredi A, Rivet JM, Auclair A, Peglion JL.
    J Pharmacol Exp Ther; 2001 Aug; 298(2):565-80. PubMed ID: 11454918
    [Abstract] [Full Text] [Related]

  • 6. Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity.
    Vaishnavi SN, Nemeroff CB, Plott SJ, Rao SG, Kranzler J, Owens MJ.
    Biol Psychiatry; 2004 Feb 01; 55(3):320-2. PubMed ID: 14744476
    [Abstract] [Full Text] [Related]

  • 7. Neurochemical and behavioural characterization of milnacipran, a serotonin and noradrenaline reuptake inhibitor in rats.
    Mochizuki D, Tsujita R, Yamada S, Kawasaki K, Otsuka Y, Hashimoto S, Hattori T, Kitamura Y, Miki N.
    Psychopharmacology (Berl); 2002 Jul 01; 162(3):323-32. PubMed ID: 12122491
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study.
    Beyer CE, Boikess S, Luo B, Dawson LA.
    J Psychopharmacol; 2002 Dec 01; 16(4):297-304. PubMed ID: 12503828
    [Abstract] [Full Text] [Related]

  • 9. The role of alpha1- and alpha2-adrenoreceptors on venlafaxine-induced elevation of extracellular serotonin, noradrenaline and dopamine levels in the rat prefrontal cortex and hippocampus.
    Weikop P, Kehr J, Scheel-Krüger J.
    J Psychopharmacol; 2004 Sep 01; 18(3):395-403. PubMed ID: 15358984
    [Abstract] [Full Text] [Related]

  • 10. S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.
    Millan MJ, Dekeyne A, Papp M, La Rochelle CD, MacSweeny C, Peglion JL, Brocco M.
    J Pharmacol Exp Ther; 2001 Aug 01; 298(2):581-91. PubMed ID: 11454919
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats.
    Iyengar S, Webster AA, Hemrick-Luecke SK, Xu JY, Simmons RM.
    J Pharmacol Exp Ther; 2004 Nov 01; 311(2):576-84. PubMed ID: 15254142
    [Abstract] [Full Text] [Related]

  • 12. Reciprocal effects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1A receptors.
    Weikop P, Kehr J, Scheel-Krüger J.
    J Psychopharmacol; 2007 Nov 01; 21(8):795-804. PubMed ID: 17984160
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of uptake 2 (or extraneuronal monoamine transporter) by normetanephrine potentiates the neurochemical effects of venlafaxine.
    Rahman Z, Ring RH, Young K, Platt B, Lin Q, Schechter LE, Rosenzweig-Lipson S, Beyer CE.
    Brain Res; 2008 Apr 08; 1203():68-78. PubMed ID: 18321472
    [Abstract] [Full Text] [Related]

  • 14. Effect of co-administration of a serotonin-noradrenaline reuptake inhibitor and a dopamine agonist on extracellular monoamine concentrations in rats.
    Kitaichi Y, Inoue T, Izumi T, Nakagawa S, Tanaka T, Masui T, Koyama T.
    Eur J Pharmacol; 2008 Apr 28; 584(2-3):285-90. PubMed ID: 18336812
    [Abstract] [Full Text] [Related]

  • 15. Serotonin and Norepinephrine Reuptake Inhibitors.
    Shelton RC.
    Handb Exp Pharmacol; 2019 Apr 28; 250():145-180. PubMed ID: 30838456
    [Abstract] [Full Text] [Related]

  • 16. Chronic effects of antidepressants on serotonin release in rat raphe slice cultures: high potency of milnacipran in the augmentation of serotonin release.
    Nagayasu K, Kitaichi M, Nishitani N, Asaoka N, Shirakawa H, Nakagawa T, Kaneko S.
    Int J Neuropsychopharmacol; 2013 Nov 28; 16(10):2295-306. PubMed ID: 23920436
    [Abstract] [Full Text] [Related]

  • 17. Effects of 5-HT(6) receptor blockade on the neurochemical outcome of antidepressant treatment in the frontal cortex of the rat.
    Dawson LA, Li P.
    J Neural Transm (Vienna); 2003 Jun 28; 110(6):577-90. PubMed ID: 12768354
    [Abstract] [Full Text] [Related]

  • 18. Venlafaxine: discrepancy between in vivo 5-HT and NE reuptake blockade and affinity for reuptake sites.
    Béïque JC, de Montigny C, Blier P, Debonnel G.
    Synapse; 1999 Jun 01; 32(3):198-211. PubMed ID: 10340630
    [Abstract] [Full Text] [Related]

  • 19. Distinct effects of the serotonin-noradrenaline reuptake inhibitors milnacipran and venlafaxine on rat pineal monoamines.
    Muneoka K, Kuwagata M, Ogawa T, Shioda S.
    Neuroreport; 2015 Jun 17; 26(9):510-4. PubMed ID: 26016648
    [Abstract] [Full Text] [Related]

  • 20. Effect of milnacipran on extracellular monoamine concentrations in the medial prefrontal cortex of rats pre-treated with lithium.
    Kitaichi Y, Inoue T, Nakagawa S, Izumi T, Koyama T.
    Eur J Pharmacol; 2005 Jun 15; 516(3):219-26. PubMed ID: 15963494
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.